* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Tuesday, October 21, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Country music legend rushed to hospital year after heart surgery. Here’s what we know – PennLive.com

    Country Music Legend Rushed to Hospital One Year After Heart Surgery – What’s Happening Now?

    Strictly Come Dancing results: Chris Robshaw is eliminated while drag queen La Voix escapes dance-off – Yahoo

    Strictly Come Dancing results: Chris Robshaw is eliminated while drag queen La Voix escapes dance-off – Yahoo

    Placer County town of Loomis considers entertainment zone for downtown – CBS News

    Loomis Unveils Thrilling New Entertainment Zone to Revitalize Downtown

    CT Culture Corner: Robert Redford films to watch – CT Insider

    CT Culture Corner: Robert Redford films to watch – CT Insider

    Elmira’s New Entertainment Venue ‘Centertown Social’ Adding its Final Touches – WENY News

    Elmira’s New Entertainment Venue ‘Centertown Social’ Adding its Final Touches – WENY News

    Bella Thorne Shows Off Her Toned Abs in Crop Top – Yahoo

    Bella Thorne Shows Off Her Toned Abs in a Chic Crop Top

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

    3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

    3 Technology Stocks to Buy Now – Yahoo Finance

    3 Must-Buy Tech Stocks You Can’t Afford to Miss Right Now

    ‘New frontier’: Austin leaders start discussions on air taxi technology – KXAN Austin

    Austin Leaders Ignite Exciting Conversations on the Future of Air Taxi Technology

    How a Gemma model helped discover a new potential cancer therapy pathway – blog.google

    How a Gemma Model Revealed a Breakthrough Pathway for Cancer Treatment

    Italian Technology in Manufacturing: Supporting North American Industries and Keeping Production Local – Thomasnet

    How Italian Technology is Revolutionizing North American Manufacturing and Boosting Local Production

    Guide to Proteomics Project Planning: Sample Preparation Strategies – Technology Networks

    Guide to Proteomics Project Planning: Sample Preparation Strategies – Technology Networks

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Country music legend rushed to hospital year after heart surgery. Here’s what we know – PennLive.com

    Country Music Legend Rushed to Hospital One Year After Heart Surgery – What’s Happening Now?

    Strictly Come Dancing results: Chris Robshaw is eliminated while drag queen La Voix escapes dance-off – Yahoo

    Strictly Come Dancing results: Chris Robshaw is eliminated while drag queen La Voix escapes dance-off – Yahoo

    Placer County town of Loomis considers entertainment zone for downtown – CBS News

    Loomis Unveils Thrilling New Entertainment Zone to Revitalize Downtown

    CT Culture Corner: Robert Redford films to watch – CT Insider

    CT Culture Corner: Robert Redford films to watch – CT Insider

    Elmira’s New Entertainment Venue ‘Centertown Social’ Adding its Final Touches – WENY News

    Elmira’s New Entertainment Venue ‘Centertown Social’ Adding its Final Touches – WENY News

    Bella Thorne Shows Off Her Toned Abs in Crop Top – Yahoo

    Bella Thorne Shows Off Her Toned Abs in a Chic Crop Top

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

    3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

    3 Technology Stocks to Buy Now – Yahoo Finance

    3 Must-Buy Tech Stocks You Can’t Afford to Miss Right Now

    ‘New frontier’: Austin leaders start discussions on air taxi technology – KXAN Austin

    Austin Leaders Ignite Exciting Conversations on the Future of Air Taxi Technology

    How a Gemma model helped discover a new potential cancer therapy pathway – blog.google

    How a Gemma Model Revealed a Breakthrough Pathway for Cancer Treatment

    Italian Technology in Manufacturing: Supporting North American Industries and Keeping Production Local – Thomasnet

    How Italian Technology is Revolutionizing North American Manufacturing and Boosting Local Production

    Guide to Proteomics Project Planning: Sample Preparation Strategies – Technology Networks

    Guide to Proteomics Project Planning: Sample Preparation Strategies – Technology Networks

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Advisory Panel Votes Against Once-Weekly Insulin for T1D

May 26, 2024
in Health
Advisory Panel Votes Against Once-Weekly Insulin for T1D
Share on FacebookShare on Twitter

In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly basal insulin analog icodec (Novo Nordisk) don’t outweigh the increased risk for hypoglycemia in people with type 1 diabetes. 

The May 24 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee was convened specifically to advise the FDA of the benefits versus risks of icodec in people with type 1 diabetes based on the results of ONWARDS-6, one of Novo Nordisk’s randomized clinical trials of icodec. 

Five other ONWARDS trials were conducted in people with type 2 diabetes. The FDA hasn’t publicly raised concerns about efficacy and safety seen in any of those trials. 

In the phase 3a ONWARDS-6, in which 290 patients were randomized to icodec and 292 patients to once-daily degludec (Tresiba), icodec was noninferior in improving A1c at 26 weeks. However, there was a significant increase in serious or severe hypoglycemia with icodec compared with degludec (4.66 vs 1.0 events per 100 patient-years; 14 events in nine patients versus three in three patients), with the greatest incidence in the icodec group on days 2-4 after injection. None of the events resulted in treatment discontinuation or study withdrawal. 

Novo Nordisk representatives presented several possible risk mitigation strategies for icodec, including limiting use to patients wearing a continuous glucose monitor (CGM), restricting use to people with low glycemic variability, avoiding use in those with a history of hypoglycemic unawareness, and/or using alternative dosing strategies such as reducing mealtime bolus insulin doses on days 2-4 after injection. 

Panel members discussed at length whether the potential advantages of once-weekly versus daily basal dosing, such as possible improved adherence and convenience, outweighed the increased risk of hypoglycemia and whether the mitigation strategies would be workable in the real world. Regardless of their vote, most panelists agreed that the company should conduct further trials to gather evidence for the proposed mitigation strategies and determine which patients with type 1 diabetes could benefit most from the drug. 

Need for Contingencies “Makes Me Nervous”

Committee chair Cecilia C. Low Wang, MD, professor of medicine at the University of Colorado Anschutz Medical Campus, voted no to the benefits of icodec outweighing the risks, explaining: “I struggled with the vote because I think adding more treatment options…is super important for my patients with diabetes, especially my patients with type 1 diabetes, because that’s kind of an under-investigated area right now…I’m concerned that approving icodec for use at this point with inadequate data might be a disincentive for further trials, which I think are needed to use it safely in type 1 diabetes.” 

Panel member Matthew T. Drake, MD, PhD, of the Division of Endocrinology at Mayo Clinic College of Medicine, Rochester, Minnesota, also voted no, noting that “when compared to the current gold-standard degludec, which has a good safety profile in my experience, and based on review of the data today, this was an incremental increase [in hypoglycemia].”

Moreover, “I am also concerned about the potential that this would need to be sort of approved with contingencies, specifically the need for CGM. So that makes me nervous. The patients who may be most likely to benefit from this in my clinical practice are unfortunately the ones who tend to be the least likely to actually monitor their blood sugars with some regularity.”

A New Paradigm for Insulin Administration

Rita R. Kalyani, MD, professor of medicine in the Division of Endocrinology, Diabetes, & Metabolism at Johns Hopkins University School of Medicine in Baltimore, Maryland, also cited the need for further studies of patient-reported outcomes, subgroups who would benefit the most, and optimal titration schedules. 

Nonetheless, she voted yes. “As a once-weekly insulin, icodec offers a new paradigm for insulin administration, which may reduce treatment burden and facilitate medication-taking behavior for some individuals with type 1 diabetes. On the other hand, bolus dose adjustment required to prevent hypoglycemia during days 2 to 4, and potentially to prevent hyperglycemia on days 5 to 7, may add to the treatment complexity.”

However, Kalyani said, “Overall given that the primary outcome for A1c efficacy has been demonstrated as noninferior to insulin degludec, risk mitigation strategies to prevent and identify hypoglycemia in a timely manner are available ideally through CGM or alternatively self-monitoring blood glucose, and that effective treatments for hypoglycemia are readily available, guided by the compelling need to offer people with diabetes another treatment option to choose from as part of patient-centered care, my vote is yes.”

Patient representative Paul Tibbits, Jr, a health policy and communications professional in Washington, DC, also voted yes but said the decision was “a significant struggle” and icodec “is only approvable with significant caveats.” 

Tibbits added, “I certainly want to help people with diabetes, but I also don’t want to hurt them. And I think this product has the potential to do both. So, I would put the onus on the FDA to work with the applicant to make sure that if this is approved there are as many guardrails as possible to make sure we don’t harm people with type 1 diabetes.”

Technology, When Possible, Is “First Choice”

Asked to comment, endocrinologist Anne L. Peters, MD, director of the University of Southern California Westside Center for Diabetes, Los Angeles, told Medscape Medical News that automated insulin delivery (AID) systems, which only use short-acting insulin, are her first choice of treatment for patients with type 1 diabetes — and even some with type 2 diabetes — who are able to access and use them “because we’re talking about a system that is infinitely adjustable versus a system that is infinitely not adjustable…It’s night-and-day different.”

However, she also said select patients with type 1 diabetes might benefit from a once-weekly basal insulin, particularly those not using an AID system who don’t reliably take their daily doses. “This would give them a baseline of insulin that could be helpful…There are so many times when I’m in type 1 clinic in [an under-resourced part of Los Angeles] that I wish I had a once-weekly insulin because it would keep people out of the hospital…It certainly isn’t for everybody, but then nothing is.” 

Insulin icodec was approved earlier this year in Canada, Switzerland, and the European Union for people with type 1 or type 2 diabetes.

Advisory panel members are vetted for disclosures and waivers granted for participation if needed, but none were required for this meeting. Peters has reported serving on advisory boards for Abbott Diabetes Care, Becton Dickinson, Boehringer Ingelheim, Eli Lilly, Lexicon Pharmaceuticals, Livongo, Medscape, Merck, Novo Nordisk, Omada Health, Optum Health, sanofi, and Zafgen. She has reported receiving research support from Dexcom, MannKind, and AstraZeneca, and serving as a member of a speakers bureau for Novo Nordisk. 

Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X (formerly Twitter) @MiriamETucker. 

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we

Tags: advisoryhealthPanel
Previous Post

India heatwave news live: Akola hottest city in Maharashtra, Section 144 imposed

Next Post

Semaglutide Significantly Improves Chronic Kidney Disease

An update from Riane Eisler, author of “The Chalice and the Blade,” on achieving peace. – Psychology Today

An update from Riane Eisler, author of “The Chalice and the Blade,” on achieving peace. – Psychology Today

October 21, 2025
We live in a sailboat and travel the world full-time… but our lifestyle isn’t as glamorous as you’d think – Daily Mail

Living Full-Time on a Sailboat and Traveling the World: The Reality Behind the Glamour

October 21, 2025
3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

3 E Network Technology Group Limited Closes $1.5 Million Convertible Promissory Note Offering – Quiver Quantitative

October 21, 2025
This Week in Navy Sports Presented by Navy Federal Credit Union – Naval Academy Athletics

Thrilling Moments from This Week in Navy Sports

October 21, 2025
New Land Cruiser “FJ” Makes World Premiere – トヨタ自動車株式会社 公式企業サイト

Unveiling the All-New Land Cruiser “FJ”: A Bold and Exciting World Premiere

October 20, 2025
World economy resilient but underwhelming, says IMF chief – African Business

Global Economy Proves Resilient Yet Growth Falls Short, Warns IMF Chief

October 20, 2025
Country music legend rushed to hospital year after heart surgery. Here’s what we know – PennLive.com

Country Music Legend Rushed to Hospital One Year After Heart Surgery – What’s Happening Now?

October 20, 2025
Proteases in intestinal health and disease – Nature

The Vital Role of Proteases in Intestinal Health and Disease

October 20, 2025
Chloe Thurston and Mary McGrath join the Perspectives on Politics editorial team as Associate Editors – Political Science Now

Chloe Thurston and Mary McGrath Join Perspectives on Politics as New Associate Editors

October 20, 2025
African Journal of Ecology paper wins Ig Nobel Prize 2025! – Wiley Online Library

Groundbreaking African Ecology Study Wins 2025 Ig Nobel Prize!

October 20, 2025

Categories

Archives

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (877)
  • Economy (899)
  • Entertainment (21,770)
  • General (17,711)
  • Health (9,940)
  • Lifestyle (912)
  • News (22,149)
  • People (899)
  • Politics (909)
  • Science (16,110)
  • Sports (21,399)
  • Technology (15,879)
  • World (882)

Recent News

An update from Riane Eisler, author of “The Chalice and the Blade,” on achieving peace. – Psychology Today

An update from Riane Eisler, author of “The Chalice and the Blade,” on achieving peace. – Psychology Today

October 21, 2025
We live in a sailboat and travel the world full-time… but our lifestyle isn’t as glamorous as you’d think – Daily Mail

Living Full-Time on a Sailboat and Traveling the World: The Reality Behind the Glamour

October 21, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version